MRI reveals whether popular wrinkle fillers migrate after injection

NCT ID NCT07079397

Ongoing Knowledge-focused Sponsor: Erevna Innovations Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses MRI scans to see if two types of hyaluronic acid fillers (NASHA and OBT) move from where they are injected in the face. Ten adults with facial volume loss will get fillers in different areas and have three MRI scans over time. The goal is to understand how the fillers integrate and whether they migrate, which could help improve injection safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Restylane injectables (hyaluronic acid fillers)
What this could lead to: If successful, this could help doctors choose fillers that are less likely to move from the injection site, improving safety and results.
What could go wrong: This is a very small study (10 people) with no control group, so findings may not apply to everyone. It only looks at short-term migration, not long-term safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AESTHETIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AESTHETIC

Contacts and locations

Locations

Erevna Innovations Inc.

Westmount, Quebec, H3Z 1C3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.